8-K - Summit Therapeutics Inc. | StockGist

Current Report Details

Event Type

Other Event

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

8.01

Other Events. On January 29, 2026, Summit Therapeutics Inc. (the “Company”) issued a press release announcing that the U.S. Food & Drug Administration (“FDA”) h

Other Event

9.01

Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Press release, dated January 29, 2026 104 Cover Page Interactive Data File (embe

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1